Letters: Refusing to supply Alzheimer’s drug on fiscal grounds is a false economy
Full story
A letter in the paper argues that withholding an Alzheimer's drug on budget grounds is the wrong call for the health service. The writer describes the move as a false economy, meaning any savings now would likely be erased by larger costs elsewhere. No details about the drug or decision-maker appear beyond the argument itself.